The global sclerotherapy market is projected to reach USD 1,424.5 Million by 2028, growing at a CAGR of 6.3%. Escalating numbers of varicose veins, upward demand for minimally invasive processes and technological progressions concerning venous illnesses are some of the factors driving the growth of the global sclerotherapy market.
Adroit Market Research report on global sclerotherapy market gives a holistic view of the market from 2018 to 2028, which includes factors such as market drivers, restraints, opportunities and challenges. The market has been studied for historic years from 2018 to 2019, with the base year of estimation as 2020 and forecast from 2021 to 2028. The report covers the current status and future traits of the market at global as well as country level. In addition, the study also assesses the key players based on their product portfolio, geographic footprint, strategic initiatives and overall revenue. Prominent players operating in the global sclerotherapy market have been studied in detail.
Sclerotherapy has been widely used in the treatment of valvular insufficiency of superficial veins. Although sclerotherapy is normally considered safe, there are certain publications that disclose the existence of severe hostile events of sclerotherapy and this leads to safety concerns.
The global sclerotherapy market is categorized based on agent and type. On the basis of agent, the market is segmented into detergents, chemical irritants, and osmotic agents. The detergents segment dominated the market in 2020. Detergents are extensively used in the course of the treatment of varicose veins and typically all the detergent sclerosing agents are FDA accepted, have greater efficacy, and low threats or side effects linked throughout the injection.
North America dominated the market for sclerotherapy in 2020, while Asia Pacific is set to grow at a highest CAGR due to sedentary lifestyle in developing economies. Key players of the global sclerotherapy market include BTG, LGM Pharma, Merz Pharma, Kreussler, Troikaa, Bioniche Pharma Group Ltd., ChanganTianyu group, Omega Pharmaceuticals, Endo-Flex among others.
Key segments of the global sclerotherapy market
Agent Overview, 2018-2028 (USD Million)
- Chemical Irritants
- Osmotic Agents
Type Overview, 2018-2028 (USD Million)
- Ultrasound Sclerotherapy
- Liquid Sclerotherapy
- Foam Sclerotherapy
Regional Overview, 2018-2028 (USD Million)
- North America
- United Kingdom
- Asia Pacific
- Latin America
- Middle East & Africa
- South Africa